Virus injection takes on Hard-to-Treat cancers
Disease control
Recruiting now
This early-phase study tests a specially designed virus (GO306) that targets and kills cancer cells. It is for people with advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose and understand side effects. The virus is inject…
Phase: PHASE1 • Sponsor: GeneSail Biotech (Shanghai) Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:59 UTC